Specific bioreactors and culture conditions are provided for the expansion of hematopoietic stem cells. These cells may be used directly for treatment post marrow ablation, or may be further differentiated into specific hematological cells for treatment of specific diseases.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.